Visionary Holdings Inc. GV 深 沪
已收盘 02-06 16:00:00 美东时间
1.21
+0.120
+11.01%
华盛通- 最 高1.23
- 今 开1.1521
- 成交量 2.73万股
- 最 低 1.135
- 昨 收 1.09
- 总市值 678.49万
- 52周最高 9.60
- 市盈率 静 --
- 换手率 0.49%
- 52周最低 1.0224
- 委 比 20.48%
- 总股本 560.73万
- 历史最高 420.00
- 量 比 0.43
- 振 幅 8.72%
- 历史最低 1.0224
- 每 手 1
- 风险率 0.95%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Visionary Holdings Inc. Regains Compliance with Nasdaq Periodic Filing Requirement
Visionary Holdings Inc. has regained compliance with Nasdaq Listing Rule 5250(c)(1) after filing its delayed Annual Report on Form 20-F for the fiscal year ended March 31, 2025. Nasdaq confirmed the compliance on January 29, 2026, closing the related matter. The company remains committed to maintaining full compliance with Nasdaq listing standards and U.S. securities laws.
02-02 14:30
CORRECTION – Visionary Holdings Inc. Releases Final Fiscal Year 2025 Annual Report and Audited Financial Statements; Form 20-F Filing Pending
Visionary Holdings Inc. 公布了截至2025年3月31日的最终年度报告和审计财务报表，尽管仍未向美国证交会提交Form 20-F。公司正从传统教育和房地产转型至健康管理、抗衰老及高端医美领域。2025财年总收入504万美元，同比下滑46.2%，新兴健康业务占总收入21.1%。净亏损1575万美元，主要源于转型投资和资产减值。毛利率增至28%，运营现金流为297万美元。未来，公司将深化健康管理和医美商业化，优化AI教育，并加强企业治理。
01-21 02:37
CORRECTION – Visionary Holdings Inc.
Visionary Holdings Inc. released its final FY2025 annual report and audited financial statements, showing total revenue of USD5.04 million, a 46.2% YoY decrease, with emerging health-related businesses contributing USD1.06 million (21.1% of total revenue). The company reported a net loss of USD15.75 million, primarily due to transformation investments and asset impairment charges. Gross margin improved to 28.0%, and cash flow from investing activ...
01-14 03:36
Visionary Holdings Inc. Reports Fiscal Year 2025 Annual Report
Visionary Holdings Inc. reported its fiscal year 2025 results, highlighting strategic transformation from traditional education and real estate to a diversified platform focused on health management, anti-aging, and premium medical aesthetics, alongside AI education. Revenue totaled USD 5.04 million, a 46.2% year-over-year decrease, with emerging health businesses contributing USD 1.06 million (21.1% of total revenue). The company incurred a net ...
01-13 04:38
Visionary Holdings (Nasdaq: GV) Appoints CEO of Health Technology Business, Establishes New Sales Entity in Nanjing to Accelerate Commercial Execution in China Market
Visionary Holdings Inc. announced the appointment of Ms. Wenxuan Cai as CEO of its wholly owned subsidiary, Visionary Health Technology Group Limited (GV Hong Kong), and the establishment of a new wholly owned subsidiary in Nanjing, China, focused on sales execution and market development. This marks GV's transition from strategic positioning to active revenue generation. Ms. Cai, with extensive experience in market expansion and brand commercial...
2025-12-30 14:30
Why Keysight Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Shares of Keysight Technologies Inc (NYSE:KEYS) rose sharply in pre-market trad...
2025-11-25 18:50
Visionary Holdings Elects William T. Chai As Board Chairman
Visionary Holdings Inc. (hereinafter referred to as the "Company", NASDAQ: GV) successfully convened the First Meeting of the Fourth Board of Directors. In strict compliance with the Business Corporations Act
2025-11-04 22:38
Visionary Holdings gets Nasdaq compliance notice
Visionary Holdings (NASDAQ:GV) received a notification letter from the listing qualifications department of Nasdaq indicating that the company is not in compliance with listing rule due to its delay i...
2025-10-27 15:35
Visionary Holdings And Yike Regenerative Medical Technology Co. Form Joint Venture To Advance Stem Cell Therapies In North America
Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (NASDAQ:GV), today announced the signing of a strategic cooperation agreement with Jiangsu Yike Regenerative
2025-10-22 21:32
